Share Price and Basic Stock Data
Last Updated: November 8, 2025, 3:40 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Puravankara Ltd operates within the construction and contracting industry, focusing on residential and commercial real estate development. As of October 2023, the company’s market capitalization stood at ₹6,416 Cr, with its share price at ₹271. The revenue from operations for the fiscal year ending March 2025 was reported at ₹2,014 Cr, a decline from ₹2,185 Cr recorded in March 2024. However, the trailing twelve months (TTM) revenue indicates a healthy figure of ₹1,880 Cr. Quarterly sales figures showcased a volatile trend, commencing at ₹215 Cr in June 2022 and peaking at ₹920 Cr in March 2024. The latest quarterly report for June 2024 recorded sales of ₹658 Cr, reflecting a notable recovery from the prior quarters. This revenue growth trajectory demonstrates the company’s potential to capitalize on the growing demand in the real estate sector, as urbanization and housing needs continue to escalate across India.
Profitability and Efficiency Metrics
Puravankara’s profitability metrics reveal a challenging landscape, with net profits declining to ₹-183 Cr for the fiscal year ending March 2025, down from ₹42 Cr in March 2024. The operating profit margin (OPM) reflected a downward trend, recorded at 14% for March 2025, compared to 21% in March 2024. The company reported a return on equity (ROE) of 10.0% and a return on capital employed (ROCE) of 6.04%, indicating subpar efficiency relative to industry standards. The interest coverage ratio (ICR) stood at 0.66x, highlighting potential challenges in meeting interest obligations. Additionally, the cash conversion cycle (CCC) was reported at 84 days, suggesting potential inefficiencies in managing receivables and payables. Overall, while Puravankara has shown some operational resilience, its profitability metrics point toward significant challenges that need to be addressed for sustainable growth.
Balance Sheet Strength and Financial Ratios
Puravankara Ltd’s balance sheet reflects a mix of strengths and vulnerabilities. Total borrowings increased to ₹4,332 Cr in March 2025, up from ₹3,325 Cr in March 2024, indicating an escalating debt burden. The debt-to-equity ratio stood at 2.48x, significantly higher than typical sector norms, suggesting potential leverage concerns. Despite these challenges, the company reported reserves of ₹1,612 Cr, providing some cushion against financial stresses. The price-to-book value ratio (P/BV) was recorded at 3.37x, indicating that the market values the company at a premium compared to its book value. Furthermore, the current ratio, a measure of short-term liquidity, was reported at 1.05x, indicating a marginally stable liquidity position. However, the quick ratio of 0.18x indicates potential liquidity risks, reflecting an over-reliance on inventory for meeting short-term obligations.
Shareholding Pattern and Investor Confidence
Puravankara’s shareholding pattern reveals a strong promoter commitment, with promoters holding 75% of the total shares. The foreign institutional investors (FIIs) accounted for 17.23%, while domestic institutional investors (DIIs) held a mere 0.49%, suggesting limited institutional interest in the stock. The public shareholding stood at 7.28%, with approximately 42,246 shareholders recorded. This distribution indicates a solid foundation of promoter support, which can instill confidence among retail investors. However, the low DII participation may reflect concerns regarding the company’s recent financial performance, particularly its declining net profits. Investor sentiment may be further influenced by the company’s ability to navigate its operational challenges effectively, especially in light of its fluctuating revenue and profitability metrics. The stability of promoter holdings coupled with the declining investor confidence from institutional players poses a dual-edged sword for Puravankara’s future.
Outlook, Risks, and Final Insight
Looking ahead, Puravankara faces both opportunities and risks that could shape its trajectory in the real estate sector. The ongoing urbanization and housing demand in India present significant growth prospects, particularly if the company can enhance its operational efficiency and profitability. However, the increasing debt levels and declining net profits pose considerable risks, necessitating a strategic focus on cost management and revenue stabilization. Additionally, the fluctuating interest coverage ratio raises concerns about financial sustainability, especially in a rising interest rate environment. The company’s ability to maintain its market position will depend on its responsiveness to these challenges and its strategic initiatives to improve financial health. Overall, while Puravankara has the potential to tap into the growing market, it must navigate its operational hurdles and enhance investor confidence to secure a stable growth path.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Puravankara Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Techindia Nirman Ltd | 20.1 Cr. | 14.0 | 39.9/13.8 | 7.62 | 0.00 % | 0.70 % | 7.32 % | 10.0 | |
| Tarmat Ltd | 129 Cr. | 51.3 | 92.6/45.0 | 64.0 | 72.0 | 0.00 % | 1.55 % | 0.92 % | 10.0 |
| Supreme Infrastructure India Ltd | 239 Cr. | 92.9 | 162/80.6 | 2,425 | 0.00 % | % | % | 10.0 | |
| SPML Infra Ltd – a Multi-sector Infrastructure Player | 1,594 Cr. | 221 | 323/136 | 33.8 | 108 | 0.00 % | 8.91 % | 7.78 % | 2.00 |
| SKIL Infrastructure Ltd | 26.6 Cr. | 1.23 | 5.85/1.12 | 2.99 | 8.93 | 0.00 % | 1.10 % | 4.76 % | 10.0 |
| Industry Average | 7,302.43 Cr | 233.47 | 63.69 | 211.76 | 0.04% | 6.52% | 9.16% | 7.10 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 215 | 239 | 392 | 389 | 323 | 368 | 574 | 920 | 658 | 496 | 318 | 542 | 524 |
| Expenses | 158 | 195 | 283 | 373 | 260 | 283 | 378 | 808 | 528 | 384 | 302 | 511 | 458 |
| Operating Profit | 57 | 45 | 110 | 16 | 63 | 85 | 196 | 112 | 130 | 112 | 16 | 30 | 67 |
| OPM % | 26% | 19% | 28% | 4% | 19% | 23% | 34% | 12% | 20% | 23% | 5% | 6% | 13% |
| Other Income | 82 | 13 | 18 | 91 | 13 | 13 | 22 | 27 | 18 | 32 | 17 | 22 | 14 |
| Interest | 88 | 76 | 94 | 102 | 98 | 105 | 105 | 127 | 119 | 141 | 143 | 152 | 161 |
| Depreciation | 4 | 4 | 5 | 4 | 5 | 6 | 7 | 10 | 7 | 8 | 8 | 11 | 10 |
| Profit before tax | 48 | -22 | 29 | 1 | -28 | -13 | 106 | 3 | 22 | -5 | -118 | -111 | -90 |
| Tax % | 28% | -22% | 22% | -2,093% | -36% | -13% | 27% | 352% | 31% | 257% | -22% | -21% | -24% |
| Net Profit | 34 | -17 | 23 | 27 | -18 | -11 | 78 | -7 | 15 | -17 | -93 | -88 | -69 |
| EPS in Rs | 1.45 | -0.72 | 0.95 | 1.12 | -0.75 | -0.47 | 3.29 | -0.28 | 0.64 | -0.71 | -3.90 | -3.62 | -2.85 |
Last Updated: August 20, 2025, 4:55 am
Below is a detailed analysis of the quarterly data for Puravankara Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 524.00 Cr.. The value appears to be declining and may need further review. It has decreased from 542.00 Cr. (Mar 2025) to 524.00 Cr., marking a decrease of 18.00 Cr..
- For Expenses, as of Jun 2025, the value is 458.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 511.00 Cr. (Mar 2025) to 458.00 Cr., marking a decrease of 53.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Mar 2025) to 67.00 Cr., marking an increase of 37.00 Cr..
- For OPM %, as of Jun 2025, the value is 13.00%. The value appears strong and on an upward trend. It has increased from 6.00% (Mar 2025) to 13.00%, marking an increase of 7.00%.
- For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 22.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 8.00 Cr..
- For Interest, as of Jun 2025, the value is 161.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 152.00 Cr. (Mar 2025) to 161.00 Cr., marking an increase of 9.00 Cr..
- For Depreciation, as of Jun 2025, the value is 10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -90.00 Cr.. The value appears strong and on an upward trend. It has increased from -111.00 Cr. (Mar 2025) to -90.00 Cr., marking an increase of 21.00 Cr..
- For Tax %, as of Jun 2025, the value is -24.00%. The value appears to be improving (decreasing) as expected. It has decreased from -21.00% (Mar 2025) to -24.00%, marking a decrease of 3.00%.
- For Net Profit, as of Jun 2025, the value is -69.00 Cr.. The value appears strong and on an upward trend. It has increased from -88.00 Cr. (Mar 2025) to -69.00 Cr., marking an increase of 19.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is -2.85. The value appears strong and on an upward trend. It has increased from -3.62 (Mar 2025) to -2.85, marking an increase of 0.77.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:13 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,310 | 1,672 | 1,584 | 1,407 | 1,415 | 2,050 | 2,128 | 963 | 955 | 1,236 | 2,185 | 2,014 | 1,880 |
| Expenses | 835 | 1,287 | 1,244 | 998 | 1,110 | 1,612 | 1,681 | 681 | 746 | 1,006 | 1,730 | 1,723 | 1,655 |
| Operating Profit | 476 | 386 | 340 | 409 | 305 | 439 | 447 | 282 | 208 | 230 | 456 | 291 | 225 |
| OPM % | 36% | 23% | 21% | 29% | 22% | 21% | 21% | 29% | 22% | 19% | 21% | 14% | 12% |
| Other Income | 18 | 18 | 47 | 68 | 90 | 76 | 59 | 93 | 427 | 203 | 75 | 86 | 85 |
| Interest | 241 | 233 | 243 | 290 | 251 | 328 | 343 | 357 | 332 | 360 | 434 | 555 | 597 |
| Depreciation | 8 | 15 | 16 | 16 | 15 | 15 | 23 | 20 | 18 | 17 | 28 | 35 | 38 |
| Profit before tax | 244 | 156 | 128 | 171 | 129 | 172 | 140 | -2 | 286 | 55 | 68 | -212 | -324 |
| Tax % | 35% | 15% | 34% | 25% | 29% | 33% | 37% | 82% | 48% | -20% | 38% | -14% | |
| Net Profit | 160 | 133 | 83 | 129 | 91 | 114 | 88 | -4 | 148 | 67 | 42 | -183 | -266 |
| EPS in Rs | 6.75 | 5.60 | 3.49 | 5.44 | 3.85 | 4.82 | 3.73 | -0.17 | 6.22 | 2.80 | 1.78 | -7.59 | -11.08 |
| Dividend Payout % | 28% | 28% | 22% | 41% | 42% | 21% | 0% | 0% | 80% | 36% | 354% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -16.88% | -37.59% | 55.42% | -29.46% | 25.27% | -22.81% | -104.55% | 3800.00% | -54.73% | -37.31% | -535.71% |
| Change in YoY Net Profit Growth (%) | 0.00% | -20.72% | 93.02% | -84.88% | 54.73% | -48.08% | -81.74% | 3904.55% | -3854.73% | 17.42% | -498.40% |
Puravankara Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -1% |
| 3 Years: | 28% |
| TTM: | -25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -450% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 45% |
| 3 Years: | 39% |
| 1 Year: | -36% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 1% |
| 3 Years: | -1% |
| Last Year: | -10% |
Last Updated: September 5, 2025, 12:45 pm
Balance Sheet
Last Updated: September 10, 2025, 2:20 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 |
| Reserves | 2,055 | 2,142 | 2,165 | 2,248 | 2,275 | 1,738 | 1,795 | 1,777 | 1,923 | 1,868 | 1,765 | 1,612 |
| Borrowings | 1,697 | 1,793 | 2,172 | 2,067 | 2,379 | 2,895 | 2,670 | 2,835 | 2,627 | 2,944 | 3,325 | 4,332 |
| Other Liabilities | 869 | 1,109 | 1,090 | 1,814 | 2,011 | 3,973 | 3,487 | 3,697 | 3,955 | 5,125 | 6,518 | 8,169 |
| Total Liabilities | 4,739 | 5,163 | 5,546 | 6,247 | 6,783 | 8,725 | 8,071 | 8,429 | 8,623 | 10,055 | 11,727 | 14,232 |
| Fixed Assets | 92 | 112 | 88 | 114 | 125 | 128 | 122 | 111 | 96 | 107 | 163 | 232 |
| CWIP | 0 | 12 | 0 | 0 | 36 | 42 | 9 | 0 | 3 | 1 | 2 | 0 |
| Investments | 91 | 69 | 525 | 116 | 131 | 130 | 132 | 138 | 82 | 104 | 36 | 40 |
| Other Assets | 4,556 | 4,970 | 4,932 | 6,017 | 6,491 | 8,424 | 7,807 | 8,179 | 8,442 | 9,844 | 11,526 | 13,960 |
| Total Assets | 4,739 | 5,163 | 5,546 | 6,247 | 6,783 | 8,725 | 8,071 | 8,429 | 8,623 | 10,055 | 11,727 | 14,232 |
Below is a detailed analysis of the balance sheet data for Puravankara Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 119.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 119.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,612.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,765.00 Cr. (Mar 2024) to 1,612.00 Cr., marking a decrease of 153.00 Cr..
- For Borrowings, as of Mar 2025, the value is 4,332.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 3,325.00 Cr. (Mar 2024) to 4,332.00 Cr., marking an increase of 1,007.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 8,169.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,518.00 Cr. (Mar 2024) to 8,169.00 Cr., marking an increase of 1,651.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 14,232.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11,727.00 Cr. (Mar 2024) to 14,232.00 Cr., marking an increase of 2,505.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 232.00 Cr.. The value appears strong and on an upward trend. It has increased from 163.00 Cr. (Mar 2024) to 232.00 Cr., marking an increase of 69.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 2.00 Cr..
- For Investments, as of Mar 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Mar 2024) to 40.00 Cr., marking an increase of 4.00 Cr..
- For Other Assets, as of Mar 2025, the value is 13,960.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,526.00 Cr. (Mar 2024) to 13,960.00 Cr., marking an increase of 2,434.00 Cr..
- For Total Assets, as of Mar 2025, the value is 14,232.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,727.00 Cr. (Mar 2024) to 14,232.00 Cr., marking an increase of 2,505.00 Cr..
However, the Borrowings (4,332.00 Cr.) are higher than the Reserves (1,612.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 475.00 | 385.00 | 338.00 | 407.00 | 303.00 | 437.00 | 445.00 | 280.00 | 206.00 | 228.00 | 453.00 | 287.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 96 | 96 | 78 | 100 | 71 | 45 | 51 | 116 | 93 | 157 | 83 | 84 |
| Inventory Days | 1,328 | 1,718 | 6,990 | 3,052 | 2,438 | |||||||
| Days Payable | 145 | 155 | 658 | 211 | 216 | |||||||
| Cash Conversion Cycle | 96 | 1,279 | 1,641 | 100 | 6,403 | 2,886 | 2,273 | 116 | 93 | 157 | 83 | 84 |
| Working Capital Days | 425 | 372 | 536 | 502 | 410 | 180 | 153 | 488 | 580 | 322 | 32 | -27 |
| ROCE % | 13% | 9% | 9% | 10% | 8% | 10% | 10% | 8% | 13% | 7% | 10% | 6% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | -7.59 | 1.78 | 2.80 | 6.22 | -0.20 |
| Diluted EPS (Rs.) | -7.52 | 1.77 | 2.80 | 6.22 | -0.20 |
| Cash EPS (Rs.) | -6.50 | 3.25 | 2.21 | 7.18 | 0.76 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 73.19 | 79.67 | 84.05 | 86.38 | 80.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 73.19 | 79.67 | 84.05 | 86.38 | 80.49 |
| Revenue From Operations / Share (Rs.) | 84.91 | 92.14 | 52.11 | 40.26 | 40.51 |
| PBDIT / Share (Rs.) | 15.62 | 22.67 | 16.91 | 27.00 | 15.89 |
| PBIT / Share (Rs.) | 14.15 | 21.49 | 16.18 | 26.26 | 15.03 |
| PBT / Share (Rs.) | -9.21 | 3.18 | 1.02 | 12.27 | -0.01 |
| Net Profit / Share (Rs.) | -7.97 | 2.07 | 1.48 | 6.44 | -0.09 |
| NP After MI And SOA / Share (Rs.) | -7.58 | 1.78 | 2.80 | 6.22 | -0.19 |
| PBDIT Margin (%) | 18.39 | 24.60 | 32.44 | 67.08 | 39.22 |
| PBIT Margin (%) | 16.66 | 23.31 | 31.05 | 65.23 | 37.10 |
| PBT Margin (%) | -10.85 | 3.44 | 1.95 | 30.47 | -0.04 |
| Net Profit Margin (%) | -9.39 | 2.24 | 2.84 | 15.99 | -0.22 |
| NP After MI And SOA Margin (%) | -8.93 | 1.93 | 5.37 | 15.46 | -0.48 |
| Return on Networth / Equity (%) | -10.36 | 2.24 | 3.34 | 7.22 | -0.24 |
| Return on Capital Employeed (%) | 17.58 | 20.30 | 15.44 | 23.32 | 14.21 |
| Return On Assets (%) | -1.26 | 0.36 | 0.66 | 1.71 | -0.05 |
| Long Term Debt / Equity (X) | 0.06 | 0.30 | 0.23 | 0.28 | 0.28 |
| Total Debt / Equity (X) | 2.48 | 1.74 | 1.47 | 1.28 | 0.74 |
| Asset Turnover Ratio (%) | 0.15 | 0.20 | 0.13 | 0.10 | 0.08 |
| Current Ratio (X) | 1.05 | 1.12 | 1.19 | 1.30 | 1.24 |
| Quick Ratio (X) | 0.18 | 0.20 | 0.18 | 0.15 | 0.16 |
| Inventory Turnover Ratio (X) | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 353.52 | 178.36 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 212.48 | 141.82 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | -253.52 | -78.36 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | -112.48 | -41.82 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 0.66 | 1.24 | 1.11 | 1.93 | 1.06 |
| Interest Coverage Ratio (Post Tax) (X) | 0.65 | 1.11 | 1.10 | 1.46 | 0.99 |
| Enterprise Value (Cr.) | 9420.43 | 7334.08 | 4121.77 | 4843.19 | 2925.63 |
| EV / Net Operating Revenue (X) | 4.68 | 3.36 | 3.34 | 5.07 | 3.05 |
| EV / EBITDA (X) | 25.43 | 13.64 | 10.28 | 7.56 | 7.76 |
| MarketCap / Net Operating Revenue (X) | 2.91 | 2.28 | 1.25 | 2.65 | 1.74 |
| Retention Ratios (%) | 0.00 | -253.52 | -78.36 | 0.00 | 0.00 |
| Price / BV (X) | 3.37 | 2.64 | 0.77 | 1.24 | 0.87 |
| Price / Net Operating Revenue (X) | 2.91 | 2.28 | 1.25 | 2.65 | 1.74 |
| EarningsYield | -0.03 | 0.01 | 0.04 | 0.05 | 0.00 |
After reviewing the key financial ratios for Puravankara Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -7.59. This value is below the healthy minimum of 5. It has decreased from 1.78 (Mar 24) to -7.59, marking a decrease of 9.37.
- For Diluted EPS (Rs.), as of Mar 25, the value is -7.52. This value is below the healthy minimum of 5. It has decreased from 1.77 (Mar 24) to -7.52, marking a decrease of 9.29.
- For Cash EPS (Rs.), as of Mar 25, the value is -6.50. This value is below the healthy minimum of 3. It has decreased from 3.25 (Mar 24) to -6.50, marking a decrease of 9.75.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 73.19. It has decreased from 79.67 (Mar 24) to 73.19, marking a decrease of 6.48.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 73.19. It has decreased from 79.67 (Mar 24) to 73.19, marking a decrease of 6.48.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 84.91. It has decreased from 92.14 (Mar 24) to 84.91, marking a decrease of 7.23.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 15.62. This value is within the healthy range. It has decreased from 22.67 (Mar 24) to 15.62, marking a decrease of 7.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.15. This value is within the healthy range. It has decreased from 21.49 (Mar 24) to 14.15, marking a decrease of 7.34.
- For PBT / Share (Rs.), as of Mar 25, the value is -9.21. This value is below the healthy minimum of 0. It has decreased from 3.18 (Mar 24) to -9.21, marking a decrease of 12.39.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -7.97. This value is below the healthy minimum of 2. It has decreased from 2.07 (Mar 24) to -7.97, marking a decrease of 10.04.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -7.58. This value is below the healthy minimum of 2. It has decreased from 1.78 (Mar 24) to -7.58, marking a decrease of 9.36.
- For PBDIT Margin (%), as of Mar 25, the value is 18.39. This value is within the healthy range. It has decreased from 24.60 (Mar 24) to 18.39, marking a decrease of 6.21.
- For PBIT Margin (%), as of Mar 25, the value is 16.66. This value is within the healthy range. It has decreased from 23.31 (Mar 24) to 16.66, marking a decrease of 6.65.
- For PBT Margin (%), as of Mar 25, the value is -10.85. This value is below the healthy minimum of 10. It has decreased from 3.44 (Mar 24) to -10.85, marking a decrease of 14.29.
- For Net Profit Margin (%), as of Mar 25, the value is -9.39. This value is below the healthy minimum of 5. It has decreased from 2.24 (Mar 24) to -9.39, marking a decrease of 11.63.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -8.93. This value is below the healthy minimum of 8. It has decreased from 1.93 (Mar 24) to -8.93, marking a decrease of 10.86.
- For Return on Networth / Equity (%), as of Mar 25, the value is -10.36. This value is below the healthy minimum of 15. It has decreased from 2.24 (Mar 24) to -10.36, marking a decrease of 12.60.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.58. This value is within the healthy range. It has decreased from 20.30 (Mar 24) to 17.58, marking a decrease of 2.72.
- For Return On Assets (%), as of Mar 25, the value is -1.26. This value is below the healthy minimum of 5. It has decreased from 0.36 (Mar 24) to -1.26, marking a decrease of 1.62.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.30 (Mar 24) to 0.06, marking a decrease of 0.24.
- For Total Debt / Equity (X), as of Mar 25, the value is 2.48. This value exceeds the healthy maximum of 1. It has increased from 1.74 (Mar 24) to 2.48, marking an increase of 0.74.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.15. It has decreased from 0.20 (Mar 24) to 0.15, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.05. This value is below the healthy minimum of 1.5. It has decreased from 1.12 (Mar 24) to 1.05, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 1. It has decreased from 0.20 (Mar 24) to 0.18, marking a decrease of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.03, marking an increase of 0.03.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 353.52 (Mar 24) to 0.00, marking a decrease of 353.52.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 212.48 (Mar 24) to 0.00, marking a decrease of 212.48.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has increased from -253.52 (Mar 24) to 0.00, marking an increase of 253.52.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has increased from -112.48 (Mar 24) to 0.00, marking an increase of 112.48.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 3. It has decreased from 1.24 (Mar 24) to 0.66, marking a decrease of 0.58.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 3. It has decreased from 1.11 (Mar 24) to 0.65, marking a decrease of 0.46.
- For Enterprise Value (Cr.), as of Mar 25, the value is 9,420.43. It has increased from 7,334.08 (Mar 24) to 9,420.43, marking an increase of 2,086.35.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.68. This value exceeds the healthy maximum of 3. It has increased from 3.36 (Mar 24) to 4.68, marking an increase of 1.32.
- For EV / EBITDA (X), as of Mar 25, the value is 25.43. This value exceeds the healthy maximum of 15. It has increased from 13.64 (Mar 24) to 25.43, marking an increase of 11.79.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.91. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 2.91, marking an increase of 0.63.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has increased from -253.52 (Mar 24) to 0.00, marking an increase of 253.52.
- For Price / BV (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 3. It has increased from 2.64 (Mar 24) to 3.37, marking an increase of 0.73.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.91. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 2.91, marking an increase of 0.63.
- For EarningsYield, as of Mar 25, the value is -0.03. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to -0.03, marking a decrease of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Puravankara Ltd:
- Net Profit Margin: -9.39%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.58% (Industry Average ROCE: 6.52%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -10.36% (Industry Average ROE: 9.16%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.65
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.18
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 63.69)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.48
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -9.39%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Realty | No.130/1, Ulsoor Road, Bengaluru Karnataka 560042 | info@puravankara.com http://www.puravankara.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ravi Puravankara | Chairman |
| Mr. Ashish Ravi Puravankara | Managing Director |
| Mr. Abhishek Kapoor | Executive Director |
| Mr. Anup Shah Sanmukh | Independent Director |
| Prof. Shailaja Jha | Independent Director |
| Mr. K G Krishnamurthy | Independent Director |
FAQ
What is the intrinsic value of Puravankara Ltd?
Puravankara Ltd's intrinsic value (as of 07 November 2025) is 83.60 which is 67.34% lower the current market price of 256.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 6,079 Cr. market cap, FY2025-2026 high/low of 464/205, reserves of ₹1,612 Cr, and liabilities of 14,232 Cr.
What is the Market Cap of Puravankara Ltd?
The Market Cap of Puravankara Ltd is 6,079 Cr..
What is the current Stock Price of Puravankara Ltd as on 07 November 2025?
The current stock price of Puravankara Ltd as on 07 November 2025 is 256.
What is the High / Low of Puravankara Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Puravankara Ltd stocks is 464/205.
What is the Stock P/E of Puravankara Ltd?
The Stock P/E of Puravankara Ltd is .
What is the Book Value of Puravankara Ltd?
The Book Value of Puravankara Ltd is 68.3.
What is the Dividend Yield of Puravankara Ltd?
The Dividend Yield of Puravankara Ltd is 0.00 %.
What is the ROCE of Puravankara Ltd?
The ROCE of Puravankara Ltd is 6.04 %.
What is the ROE of Puravankara Ltd?
The ROE of Puravankara Ltd is 10.0 %.
What is the Face Value of Puravankara Ltd?
The Face Value of Puravankara Ltd is 5.00.